406 filings
Page 3 of 21
425
bdzidbm shen
9 May 11
Business combination disclosure
12:00am
8-K
r5dpwp
9 May 11
Important Additional Information and Where to Find It
12:00am
8-K
j02jaiiy oxci47nv
9 May 11
Entry into a Material Definitive Agreement
12:00am
425
wkil9 6f39wwvl
9 May 11
Business combination disclosure
12:00am
DEFA14A
988hdme5xydah
9 May 11
Additional proxy soliciting materials
12:00am
425
1s8q1gml
9 May 11
Business combination disclosure
12:00am
425
0s1dy5vy
9 May 11
Business combination disclosure
12:00am
8-K
eey04r09 3pee
15 Apr 11
Bydureon™ Recommended for Approval In Europe
12:00am
8-K
0mnghk148rtsqkp38cs
24 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
so0 l1lpvo
10 Mar 11
Exenatide Once Monthly Showed Positive Results In Phase 2 Study
12:00am
8-K
kzc6fb dppqdzj
3 Mar 11
DURATION-6 Top-Line Study Results Announced
12:00am
8-K
dpqr eor1klvhw7sf
3 Feb 11
Alkermes Reports Third Quarter Fiscal 2011 Financial Results
12:00am
8-K
7g0c5z0
27 Jan 11
Regulation FD Disclosure
12:00am
8-K
2h2tds9n te0tjjr
18 Jan 11
Alkermes Elects Wendy L. Dixon, PH.D., to Board of Directors
12:00am
8-K
sltueoxk
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
dwpjn 88qbt1mjs
20 Oct 10
Regulation FD Disclosure
12:00am
8-K
0rejayju6dr18h
13 Oct 10
Regulation FD Disclosure
12:00am
8-K
vj0e83lei046rop
5 Oct 10
Submission of Matters to a Vote of Security Holders
12:00am